Skip to main content
. Author manuscript; available in PMC: 2016 Sep 29.
Published in final edited form as: Psychosom Med. 2013 Jun 20;75(6):537–544. doi: 10.1097/PSY.0b013e31829a0ae3

Table 2.

Relationships between anxious symptoms and measures of vascular function

Atherosclerotic Participants Healthy Control Participants

Variable Standardized β p-value Standardized β p-value
FMD −0.065 0.56 0.133 0.35
NTG −0.098 0.40 −0.108 0.45
Acetylcholine −0.302 0.004 0.129 0.36
Nitroprusside −0.228 0.031 0.180 0.20
Verapamil −0.285 0.007 0.114 0.43

Note: Measures of forearm conduit vessel function are flow-mediated dilatation (FMD; % change from baseline) of the brachial artery, as well as the nitroglycerine-mediated (NTG; % change from baseline) response. Measures of forearm resistance vessel function are change (%) in blood flow in response to intra-arterial infusion of acetylcholine (30 μg/min), nitroprusside (10 μg/min) and verapamil (100 μg/min). Standardized beta values represent the relationship between anxiety symptoms and vascular function, not adjusted for age, gender, depression and cardiovascular risk factors. Conduit vessel standardized beta values (FMD and NTG) are adjusted only for baseline brachial artery diameter.